All lobbying filings

THORN RUN PARTNERS

THORN RUN PARTNERS filed a Q4 report for ALORA PHARMACEUTICALS, LLC on January 19, 2026, reporting $150,000 in lobbying income.

Lobbying for ALORA PHARMACEUTICALS, LLC · Drug manufacturer.

All filings by THORN RUN PARTNERS · Everything ALORA PHARMACEUTICALS, LLC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$150,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Lobbyists on this filing 3

JESSIE HOWE BRAIRTON

Previously held: Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee
STUART CHAPMAN

Previously held: Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee
ALEX DELPIZZO

Previously held: Legislative Director/Legislative Asst, Rep. Ferguson; Staff Asst, House Transportation and Infrastructure Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Healthcare issues, related to domestic manufacturing. Desiccated thyroid extract (DTE) medications.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.